EPOPROSTENOL (EPOPROSTENOL SODIUM) — all Canadian products
6 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is EPOPROSTENOL (EPOPROSTENOL SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02397447 | CARIPUL | JANSSEN INC | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 0.5 MG | Marketed | |
| 02397455 | CARIPUL | JANSSEN INC | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 1.5 MG | Marketed | |
| 02230845 | FLOLAN | GLAXOSMITHKLINE INC | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 0.5 MG | Marketed | |
| 02230848 | FLOLAN | GLAXOSMITHKLINE INC | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 1.5 MG | Marketed | |
| 02345706 | EPOPROSTENOL FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 0.5 MG | Cancelled Pre Market | |
| 02345714 | EPOPROSTENOL FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | EPOPROSTENOL (EPOPROSTENOL SODIUM) 1.5 MG | Cancelled Pre Market |
Browse other molecules: